Showing results (1751-1760 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|December 17, 2009
Erythrocytosis associated with a novel missense mutation in the HIF2A geneRichard van Wijk, Scott Sutherland, Annet C W Van Wesel, et al.
Haematologica|October 13, 2005
Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trialJosep-María Ribera, Albert Oriol, Concepción Bethencourt, et al.
Haematologica|October 13, 2005
Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemiaJe-Hwan Lee, Seong-Jun Choi, Jung-Hee Lee, et al.
Haematologica|October 13, 2005
Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cellsSusanne Hipp, Ingo Ringshausen, Madlene Oelsner, et al.
Haematologica|October 13, 2005
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53Nnenna C Osuji, Ilaria Del Giudice, Estella Matutes, et al.
Haematologica|October 13, 2005
Serum syndecan-1 in patients with newly diagnosed monoclonal proteinemiaCees G Schaar, Henricus J Vermeer, Pierre W Wijermans, et al.
Haematologica|May 19, 2018
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II studyCarlo Gambacorti-Passerini, Jorge E Cortes, Jeff H Lipton, et al.
Haematologica|May 19, 2018
Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expressionAmanda McCabe, Julianne N P Smith, Angelica Costello, et al.
Haematologica|May 19, 2018
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donorsRajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, et al.
Haematologica|May 19, 2018
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trialWeiguo Zhang, Charlie Ly, Jo Ishizawa, et al.
Pageof 816